Medicines and Healthcare products Regulatory Agency
| 1: Authorisation Number | UK MIA(IMP) 21584 |
|---|---|
| 2: Name of authorisation holder | UNIVERSITY OF OXFORD |
| 3: Address(es) of manufacturing site(s) |
UNIVERSITY OF OXFORD, GIBSON BUILDING, GROUND FLOOR, RADCLIFFE OBSERVATORY QUARTER, WOODSTOCK ROAD, OXFORD, OX2 6GG, UNITED KINGDOM CLINICAL BIOMANUFACTURING FACILITY, OLD ROAD, HEADINGTON, OXFORD, OX3 7JT, UNITED KINGDOM |
| 4: Legally registered address of authorisation holder | UNIVERSITY OF OXFORD, NUFFIELD DEPARTMENT OF MEDICINE, HENRY WELLCOME BUILDING FOR MOLECULAR PHYSIOLOGY, OLD ROAD CAMPUS, OXFORD, OX3 7BN, UNITED KINGDOM |
| 5: Scope of authorisation and dosage forms | ANNEX 1 and/ or ANNEX 2 |
| 6: Legal Basis of authorisation | |
| 7: Name of responsible officer of the competent authority of the member state granting the manufacturing authorisation | Confidential |
| 8: Authorisation Date | 28/05/2025 |
| 9: Annexes attached | Annex 1 and/or Annex 2 |
SCOPE OF AUTHORISATION
Annex 2
Name and address of the site:
UNIVERSITY OF OXFORD, GIBSON BUILDING, GROUND FLOOR, RADCLIFFE OBSERVATORY QUARTER, WOODSTOCK ROAD, OXFORD, OX2 6GG, UNITED KINGDOM
Human Investigational Medicinal Products
| Authorised Operations |
| MANUFACTURING OPERATIONS (according to part 1)IMPORTATION OF MEDICINAL PRODUCTS (according to part 2) |
| Part 1 - MANUFACTURING OPERATIONS |
| [ 1.2 ] Non-sterile investigational medicinal products |
| [ 1.2.1 ] Non-Sterile Products (processing operations for the following dosage forms) |
| [ 1.2.1.1 ] Capsules, hard shell |
| [ 1.2.1.2 ] Capsules, soft shell |
| [ 1.5 ] Packaging |
| [ 1.5.2 ] Secondary packaging |
| Part 2 - IMPORTATION OF MEDICINAL PRODUCTS |
| [ 2.2 ] Batch certification of imported medicinal products |
| [ 2.2.2 ] Non-sterile products |
| [ 2.3 ] Other Importation Activities |
| [ 2.3.1 ] Site of Physical Importation |
| [ 2.3.4 ] Other Importation of QP certified IMPs from a country on the 'approved country for import list' |
SCOPE OF AUTHORISATION
Annex 2
Name and address of the site:
CLINICAL BIOMANUFACTURING FACILITY, OLD ROAD, HEADINGTON, OXFORD, OX3 7JT, UNITED KINGDOM
Human Investigational Medicinal Products
| Authorised Operations |
| MANUFACTURING OPERATIONS (according to part 1)IMPORTATION OF MEDICINAL PRODUCTS (according to part 2) |
| Part 1 - MANUFACTURING OPERATIONS |
| [ 1.1 ] Sterile Investigational Medicinal Products |
| [ 1.1.1 ] Aseptically prepared (processing operations for the following dosage forms) |
| [ 1.1.1.1 ] Large volume liquids |
| [ 1.1.1.4 ] Small volume liquids |
| [ 1.1.1.6 ] Other aseptically prepared products Adjuvants, preparation of aseptic membranes or matrices to air dry vaccines |
| [ 1.2 ] Non-sterile investigational medicinal products |
| [ 1.2.1 ] Non-Sterile Products (processing operations for the following dosage forms) |
| [ 1.2.1.5 ] Liquids for external use |
| [ 1.2.1.6 ] Liquids for internal use |
| [ 1.2.2 ] Batch certification |
| [ 1.3 ] Biological investigational medicinal products |
| [ 1.3.1 ] Biological medicinal products |
| [ 1.3.1.1 ] Blood products |
| [ 1.3.1.2 ] Immunological products |
| [ 1.3.1.3 ] Cell therapy products |
| [ 1.3.1.4 ] Gene therapy products |
| [ 1.3.1.5 ] Biotechnology products |
| [ 1.3.1.6 ] Human or animal extracted products |
| [ 1.3.1.8 ] Other biological medicinal products SiRNA, adjuvants, biological challenge agents |
| [ 1.3.2 ] Batch certification |
| [ 1.3.2.1 ] Blood products |
| [ 1.3.2.2 ] Immunological products |
| [ 1.3.2.3 ] Cell therapy products |
| [ 1.3.2.4 ] Gene therapy products |
| [ 1.3.2.5 ] Biotechnology products |
| [ 1.3.2.6 ] Human or animal extracted products |
| [ 1.3.2.8 ] Other biological medicinal products SiRNA, adjuvants, biological challenge agents |
| [ 1.4 ] Other investigational medicinal products or manufacturing activitiy |
| [ 1.4.1 ] Manufacture of: |
| [ 1.4.1.3 ] Other Importation of QP-certified IMPs from a country on the 'approved country for import list' |
| [ 1.4.2 ] Sterilisation of active substances/excipients/finished products: |
| [ 1.4.2.1 ] Filtration |
| [ 1.5 ] Packaging |
| [ 1.5.2 ] Secondary packaging |
| [ 1.6 ] Quality control testing |
| [ 1.6.2 ] Microbiological: non-sterility |
| [ 1.6.3 ] Chemical/Physical |
| [ 1.6.4 ] Biological |
| Part 2 - IMPORTATION OF MEDICINAL PRODUCTS |
| [ 2.1 ] Quality control testing of imported medicinal products |
| [ 2.1.2 ] Microbiological: non-sterility |
| [ 2.1.3 ] Chemical/Physical |
| [ 2.1.4 ] Biological |
| [ 2.2 ] Batch certification of imported medicinal products |
| [ 2.2.1 ] Sterile Products |
| [ 2.2.1.1 ] Aseptically prepared |
| [ 2.2.1.2 ] Terminally sterilised |
| [ 2.2.2 ] Non-sterile products |
| [ 2.2.3 ] Biological medicinal products |
| [ 2.2.3.1 ] Blood products |
| [ 2.2.3.2 ] Immunological products |
| [ 2.2.3.3 ] Cell therapy products |
| [ 2.2.3.4 ] Gene therapy products |
| [ 2.2.3.5 ] Biotechnology products |
| [ 2.2.3.6 ] Human or animal extracted products |
| [ 2.2.3.8 ] Other biological medicinal products SiRNA, adjuvants, biological challenge agents |
| [ 2.3 ] Other Importation Activities |
| [ 2.3.1 ] Site of Physical Importation |
| [ 2.3.2 ] Importation of Intermediate which undergoes further processing |
| [ 2.3.3 ] Biological Active Substance |
| [ 2.3.4 ] Other Importation of QP-certified IMPs from a country on the 'approved country for import list' |